Ventura, Manuel A. Encalada; Hils, Martin; Tewes, Bernhard et al.
THE ORAL TISSUE TRANSGLUTAMINASE INHIBITOR ZED1227 PREVENTS GLUTEN-INDUCED ENTEROPATHY IN A TRANSGENIC MOUSE MODEL OF CELIAC DISEASEGASTROENTEROLOGY. Bd. 160. H. 6. 2021 S. S53-S54
Cerf-Bensussan, Nadine; Schuppan, Detlef
The Promise of Novel Therapies to Abolish Gluten Immunogenicity in Celiac DiseaseGASTROENTEROLOGY. Bd. 161. H. 1. 2021 S. 21-24
Wagner, Willi L.; Foehst, Sonja; Hock, Jessica et al.
3D analysis of microvasculature in murine liver fibrosis models using synchrotron radiation-based microtomographyANGIOGENESIS. 2020
Bockamp, Ernesto
A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression.PLoS One. 2020 S. 10
Matzner, Johannes; Pickert, Geethanjali; Thies, Dorothe et al.
A GUT-TARGETED EICOSAPENTAENOIC ACID DERIVATIVE, SEFA-1024, AMELIORATES DEXTRAN SODIUM SULFATE (DSS)-INDUCED INTESTINAL INFLAMMATIONGASTROENTEROLOGY. Bd. 158. H. 6. 2020 S. S505-S505
Schuppan, D
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.J Hepatol. Bd. 10.1016/j.jhep.2019.11.024. 2020 S. 19
Yurugi, Hajime; Zhuang, Yinyin; Siddiqui, Farid et al.
A subset of flavaglines inhibits KRAS nanoclustering and activationJOURNAL OF CELL SCIENCE. Bd. 133. H. 12. 2020
Abe, Hiroyuki; Schuppan, Detlef
beta-arrestin: Dr Jekyll and Mr Hyde in NASH and fibrosisJOURNAL OF HEPATOLOGY. Bd. 72. H. 5. 2020 S. 813-815
Ziegler, Kira; Kunert, Anna T.; Reinmuth-Selzle, Kathrin et al.
Chemical modification of pro-inflammatory proteins by peroxynitrite increases activation of TLR4 and NF-kappa B: Implications for the health effects of air pollution and oxidative stressREDOX BIOLOGY. Bd. 37. 2020
Ebert, Antonia; Koenig, Jochem; Frommer, Lara et al.
Chromogranin Serves as Novel Biomarker of Endocrine and Gastric AutoimmunityJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 105. H. 8. 2020 S. 2606-2615